cardiovascular diseases
Conditions
Interventions
Control group:Placebo
Experimental group:Xinluosu Tablets
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 35 to 65 years, gender is not limited; 2. No obvious vascular or blood system diseases; 3. No abnormality in laboratory tests: blood routine, liver and kidney function, blood sugar, blood lipids, coagulation function, etc.; 4. Healthy volunteers who signed informed consent and volunteered to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Currently taking any medication; 2. Low platelet count (whole blood <100 x 10^9/L); 3. Prothrombin time (PT) is outside the normal reference range; 4. Receive chronic medication and nutritional supplements; 5. Pregnant or breastfeeding; 6. According to the judgment of the investigator, there is a history of the following related diseases: digestive system diseases, organic diseases of the heart, liver or kidney, severe liver or kidney dysfunction, metabolic/endocrine/nervous system diseases, Neurological disorders (eg, Parkinson's disease, stroke) with residual damage, vertigo; 7. Abnormal menstrual cycle, taking contraceptives or hormone replacement therapy; or women in menopause; 8. Persons who are not suitable for venous blood collection; 9. Allergic to tomato and its components; 10. Known HIV history or active HCV/HBV infection or uncontrolled active systemic infection; 11. Have participated in or are participating in other clinical trials within three months of taking the research product for the first time; 12. Those who take fish oil and evening primrose; 13. Supplement functional foods, supplements and drugs that affect platelet function; 14. Those who cannot tolerate or are allergic to aspirin or those who are in line with the contraindication of aspirin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet aggregation ratio;blood routine examination;liver function test;Renal function test; | — |
Countries
China
Contacts
Public ContactQi Ruomei
Beijing Hospital
Outcome results
None listed